Researchers identify key pathway that drives T-cell exhaustion in cancer immunotherapy
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center used a CRISPR screen to identify a key molecular pathway that drives exhaustion in cancer-fighting immune cells, limiting their ability to keep tumors under control.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Study finds prebiotic fiber helps girls build more bone
United Kingdom
-
Antibody screening approach could speed development of immune-based cancer treatments
United Kingdom
-
Scientists restore memory-linked neuron function in Alzheimer's mice
United Kingdom
-
Who gets Alzheimer's drugs? Race, vulnerability and health status shape access
United Kingdom
-
Mount Sinai wins NIH grant to test community-based hypertension care model in rural Ghana
United Kingdom
-
Radiology departments face gaps in family medical leave policies
United Kingdom
-
Prescribing antidepressants based on patients' genetic makeup does not improve the effectiveness of treatment
United Kingdom
-
Popular sports supplement may help shield the brain from damage linked to gut inflammation
United Kingdom